Neurocrine Biosciences
NBIX
NBIX
117 hedge funds and large institutions have $547M invested in Neurocrine Biosciences in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 43 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
21% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 43
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
117
Holding in Top 10
1
Calls
$6.31M
Puts
$1.11M
Top Buyers
| 1 | +$19.2M | |
| 2 | +$7.15M | |
| 3 | +$6.5M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$4.63M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$3.95M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$11.9M | |
| 3 | -$6.54M | |
| 4 |
PC
PointState Capital
New York
|
-$5.66M |
| 5 |
VM
VHCP Management
New York
|
-$5.38M |